Planet Labs PBC
General ticker "PL" information:
- Sector: Industrials
- Industry: Aerospace & Defense
- Capitalization: $8.1B (TTM average)
Planet Labs PBC follows the US Stock Market performance with the rate: 36.0%.
Estimated limits based on current volatility of 2.5%: low 15.50$, high 16.28$
Factors to consider:
- Total employees count: 945 (-2.6%) as of 2026
- US accounted for 44.7% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: Dependence on government customers, Market competition, Launch failures, Cybersecurity threats, Geopolitical risks
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [12.29$, 26.70$]
- 2027-01-31 to 2028-01-31 estimated range: [8.82$, 19.80$]
Financial Metrics affecting the PL estimates:
- Positive: with PPE of -36.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of 1.63 <= 2.37
- Negative: Industry operating cash flow per share per price (median), % of 0.71 <= 0.90
- Negative: 12.78 < Shareholder equity ratio, % of 16.45 <= 25.20
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of 0.28 <= 0.59
- Negative: -0.92 < Industry inventory ratio change (median), % of -0.70
- Negative: 0 < Interest expense per share per price, % of 0.04
- Negative: Investing cash flow per share per price, % of -4.78 <= -4.49
Short-term PL quotes
Long-term PL plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $220.70MM | $244.35MM | $307.73MM |
| Operating Expenses | $390.44MM | $360.47MM | $402.80MM |
| Operating Income | $-169.75MM | $-116.12MM | $-95.07MM |
| Non-Operating Income | $30.05MM | $-4.61MM | $-147.13MM |
| Interest Expense | $0.00MM | $0.00MM | $3.44MM |
| R&D Expense | $116.34MM | $101.01MM | $106.75MM |
| Income(Loss) | $-139.69MM | $-120.74MM | $-242.21MM |
| Taxes | $0.81MM | $2.46MM | $4.66MM |
| Net Income(Loss)* | $-140.51MM | $-123.20MM | $-246.86MM |
| Stockholders Equity | $518.02MM | $441.29MM | $188.43MM |
| Inventory | $0.00MM | $0.00MM | $6.12MM |
| Assets | $702.00MM | $633.80MM | $1,145.69MM |
| Operating Cash Flow | $-50.71MM | $-14.37MM | $134.36MM |
| Capital expenditure | $42.41MM | $44.30MM | $76.71MM |
| Investing Cash Flow | $-33.59MM | $57.91MM | $-393.12MM |
| Financing Cash Flow | $-1.60MM | $-15.54MM | $357.05MM |
| Earnings Per Share** | $-0.50 | $-0.42 | $-0.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.